Persicoimidate isolated from Allium ampeloprasum Subsp. Persicum with Apoptotic effects against Breast cancer cell lines

Document Type : Research Paper


1 Pharmacy student, Pharmacy Student's Research Committee, School of Pharmacy, Isfahan University of Medical sciences, Isfahan, Iran

2 Department of Pharmacognosy, School of pharmacy and pharmaceutical sciences, Isfahan University of medical sciences, Isfahan, Iran

3 Department of Pharmaceutical Biotechnology, School of pharmacy and pharmaceutical sciences, Isfahan University of medical sciences, Isfahan, Iran



Breast cancer is the most common malignancy among American women and the second leading cause of cancer death after the lung cancer. For this reason, trying to find new drugs for the treatment of this disease is essential. The aim of the present study was to evaluate the cytotoxic effects of three cinnamic acid derivatives isolated from Allium ampeloprasum var. Persicum including Caffeoyl tyramine, Feruloyl tyramine, and Persicoimidate on two breast cancer cell lines, MCF-7 and BT-474. Evaluation the cytotoxic effects of mentioned purified compounds against MCF-7 and BT-474 cells was performed using MTT assay and their IC50 was determined. Finally, flow cytometery analysis on MCF-7 cells was performed and used to determine the cell death mechanism of investigated compounds. The results exhibited that the cytotoxic effects of all three compounds against breast cancer cell lines was concentration-dependent. The IC50 of Caffeoyl tyramine, Feruloyl tyramine, and Persicoimidate was determined to be as 73, 56, and 40 μg/ml for MCF-7 and 100, 54, and 37 μg/ml for BT-474 cells, respectively. So, Perscicoimidate showed the most potent cytotoxic effects against two breast cancer cells. Finally, flow cytometery analysis showed that Persicoimidate caused approximately 48% of apoptosis in concentration of 40 μg/ml. According to the tyrosine kinase inhibitory activity of cinnamic acid derivatives, these compounds has the potential of being cancer drug candidates for complementary studies on breast tumors with highly expression of EGF receptor. However, evaluation of anti-cancer effects of these compounds against other breast cancer cell lines is suggested.


[1] DeSantis CE, Ma J, Goding Sauer A, Newman LA and Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA. Cancer J. Clin. (2017) 67: 439-48.
[2] Tagne SR, Armel HNK and Farah M. Medicinal Plants in Breast Cancer Therapy. J. Dis. Med. Plants (2015) 1: 19-23.
[3] Ma H, Carpenter CL, Sullivan-Halley J and Bernstein L. The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors-results of a prospective study. BMC Cancer (2011) 11: 222-31.
[4] Sadeghi M, Zolfaghari B, Senatore M and Lanzotti V. Antifungal cinnamic acid derivatives from Persian leek (Allium ampeloprasum subsp. persicum). Phytochem. Lett. (2013) 6: 360-3.
[5] Park JB and Schoene N. N-Caffeoyl tyramine arrests growth of U937 and Jurkat cells by inhibiting protein tyrosine phosphorylation and inducing caspase-3. Cancer Lett. (2003) 202: 161-71.
[6] Kunduzova OR, Bianchi P, Pizzinat N, Escourrou G, Seguelas MH, Parini A and Cambon C. Regulation of JNK/ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. FASEB J. (2002) 16: 1129-31.
[7] Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L and Courtneidge SA. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. (2000) 20: 9018-27.
[8] Subik K, Lee JF, Baxter L, Strzepek T, Costello D, Crowley P, Xing L, Hung MC, Bonfiglio T, Hicks DG and Tang P. The expression patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines. Breast Cancer (2010) 4: 35-41.
[9] Manasa J, Musabaike H, Masimirembwa C, Burke E, Luthy R and Mudzori J. Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe. Clin. Vaccine Immunol. (2007) 14: 293-8.
[10] Hadjipavlou-Litina D and Pontiki E. Aryl-acetic and cinnamic acids as lipoxygenase inhibitors with antioxidant, anti-inflammatory, and anticancer activity. Advanced protocols in oxidative stress III, Humana Press, New York (2015) 361-377.
[11] De P, Baltas M and Bedos-Belval F. Cinnamic acid derivatives as anticancer agents-a review. Curr. Med. Chem. (2011) 18: 1672-703.
[12] Ekmekcioglu C, Feyertag J and Marktl W. Cinnamic acid inhibits proliferation and modulates brush border membrane enzyme activities in Caco-2
cells. Cancer Lett. (1998) 128: 137-44.
[13] Pontiki E, Hadjipavlou-Litina D, Litinas K and Geromichalos G. Novel cinnamic acid derivatives as antioxidant and anticancer agents: Design, synthesis and modeling studies. Molecules (2014) 19: 9655-74.
[14] Lee DG, Park Y, Kim MR, Jung HJ, Seu YB, Hahm KS and Woo ER. Anti-fungal effects of phenolic amides isolated from the root bark of Lycium chinense. Biotechnol. Lett. (2004) 26: 1125-30.
[15] De Oliveira Niero EL and Machado-Santelli GM. Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells. J. Exp. Clin. Cancer Res. (2013) 32: 31-44.